Aurobindo Pharma bonus shares and stock split history
NSE: AUROPHARMABSE: 524804Pharmaceuticals & BiotechnologyMid Cap
Aurobindo Pharma Limited · Face value ₹1 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Apr 1995 on BSE, Jul 2000 on NSE
Last close ₹1,627.50up ₹37.50 (2.36%)BSE ₹1,633.00
Share price at the NSE close on 27 Oct 2026. Previous close ₹1,590.00.
27 Oct: open ₹1,600.00, high ₹1,635.00, low ₹1,597.20
52-week range of traded prices to 27 Oct 2026
₹1,081.40Low, 28 Oct 2025₹1,740.00High, 24 Sep 2026
- Next results date: the board meets on 4 Nov 2026 to consider: financial results and dividend. The notice · Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹93,643 Cr138th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 25.22
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 2.47
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 10.5%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 11.5%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.20
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 11,64,93260.5% delivered
Aurobindo Pharma's one bonus issue and one split since Jan 2007, the latest gone ex on 20 Jul 2015, with each one's ratio, ex-date and record date and what one share held before them became.
What one share became
Neither changes what a holding is worth on the day.Aurobindo Pharma dividend history
One share held before 10 Feb 201110 shares todayShares today for one share held before. One share multiplied by the share factor of this bonus or split and of every one after it: a 1:1 bonus doubles the count, and a split of a ₹10 share into ₹2 shares multiplies it by five. Shares today for one share held before in the glossary
- Bonus issues
- 1
- Splits
- 1
Bonus issues: ratio, ex-date and record date
A bonus issue gives holders free extra shares in a fixed ratio. On record from 2007.All upcoming bonus issues
Shares today for one held before the ex-date, after every event since
- 20 Jul 2015 · ex-date1 for 1 bonusRecord date 21 Jul 20152 shares todayfor 1 held before 20 Jul 2015
Stock splits: face value, ex-date and record date
A stock split, or share split, divides each share into more shares of a lower face value. On record from 2007.All upcoming stock splits
Shares today for one held before the ex-date, after every event since
- 10 Feb 2011 · ex-dateEach share became 5, face value ₹5 to ₹1Record date 11 Feb 201110 shares todayfor 1 held before 10 Feb 2011
Buybacks
Every one on record, latest first.
- Buyback · 17 Apr 2026 · record date 17 Apr 2026Tender offer to holders on the record date at ₹1,475 a share, open 23 Apr 2026 to 29 Apr 2026.
- Buyback · 30 Jul 2024 · record date 30 Jul 2024Tender offer to holders on the record date at ₹1,460 a share, open 5 Aug 2024 to 9 Aug 2024.